SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony,

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pilapir who wrote (80778)10/4/2002 5:46:58 PM
From: afrayem onigwecher  Read Replies (4) of 122087
 
Dow Jones Business News

Genemax Corp Sues Firms, Alleges Short Sales
Thursday October 3, 3:35 pm ET

BLAINE, Wash. -(Dow Jones)- Genemax Corp. (GMXX) filed a lawsuit against various broker-dealers, market makers and clearing agents alleging short selling of Genemax's securities.
In a press release Thursday, Genemax said it's seeking "substantial" damages and wants an injunction against Charles Schwab Corp. (NYSE:SCH - News) , Knight Trading Group Inc.'s Knight Securities L.P. unit and other defendants.
A Charles Schwab spokesman said his firm had no comment on the suit.

The complaint, which also alleges fraud, negligence and violation of securities laws, was filed in the U.S. District Court for the District of Nevada.

The other defendants are Herzog Heine Geguld Inc. , Wm. V. Frankel & Co., ICLearnings LLC, Hill Thompson Magic L.P., VFinance Investment Inc., Ameritrade Clear, Yorktown Securities, Black Corps. 1-100 and DOES 1-100.

GeneMax is a biotechnology company whose shares trade on the over-the-counter Bulletin Board.

-Eamon Beltran; Dow Jones Newswires; 201-938-5400
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext